Myelofibrosis is a proliferative response of the bone marrow fibroblasts. Myelofibrosis can be classified as primary or secondary depending on the underlying etiology. Primary myelofibrosis is a myeloproliferative disorder in humans in which there is a clonal proliferation of a pluripotent stem cell. Hemopathology includes finding nucleated red blood cells and immature granulocytes in the circulation, extramedullary hematopoiesis, and myelofibrosis. The proliferation of the bone marrow fibroblasts is not clonal in origin. To the best of this author's knowledge, this type of myelofibrosis has not been reported to occur naturally in the dog. Secondary myelofibrosis has been reported in the dog associated with neoplastic conditions, irradiation, congenital hemolytic anemias, and a variety of unknown etiologies. It has been shown in some cases of myelofibrosis that there is often concurrent bone marrow necrosis. Bone marrow necrosis has been documented in dogs with Ehrlichiosis and septicemia, and associated with drug treatment, including estrogens and cephalosporins. It is thought that this necrosis is due to the destruction of the bone marrow microvasculature and/or hematopoietic elements. Release of growth factors by inflammatory cells may lead to the subsequent fibroblast proliferation. Several cases of secondary myelofibrosis in female laboratory beagles have been recently observed. These dogs present with a severe nonregenerative anemia and often a mild neutropenia with varying degrees of myelofibrosis in the bone marrow. Some animals have had concurrent bone marrow necrosis. At this time, the exact etiology is unknown.
A Review of Myelofibrosis in Dogs* INTRODUCTION Classification of myelofibrosis has historically been separated into primary and secondary. Primary myelofibrosis is a myeloproliferative disorder that has also been known by several different names including agnogenic myeloid metaplasia, myelosclerosis, and leukoerythroblastic anemia [reviewed by Hoffman and Silverstein in (17) and Smith et al (32) ]. This neoplastic proliferation of hematopoietic elements is characterized by dacrocytosis (teardropshaped red blood cells) and immature granulocytes and erythrocytes in the circulation. In addition, there is splenomegaly, hepatomegaly, extramedullary hematopoiesis, and myelofibrosis. Jacobson et al (21 ) showed that in humans with myelofibrosis immature white blood cells and nucleated red blood cells in the circulation represent a clonal expansion of progenitor cells. But the fibroblast response appears to be a secondary response. That is, it does not represent a clonal proliferation of fibroblasts (12) .
To this author's knowledge, true primary myelofibrosis has not been reported to occur naturally in the dog.
Secondary myelofibrosis has been documented in the dog in association with neoplastic processes (10, 33, 35) , chronic hemolytic anemias (24, 25, 30) , and unknown causes (15, 16, 33, 35) . Myelofibrosis of an unknown etiology in several beagle dogs has recently been recognized. The clinical pathology and histopathology of a few of these dogs will be reviewed, and findings in these animals will be compared to those cases of myelofibrosis in the dog that are documented in the literature. A review of the pathogenesis of myelofibrosis will follow.
BEAGLES WITH MYELOFIBROSIS
A severe nonregenerative anemia has been recently recognized in several beagle dogs. Of the dogs examined, many have had myelofibrosis. These anemic dogs are prewhelping or postwhelping female dogs that are less than 1 yr old to more than 6 yr old. The occurrence exclusively in female dogs may be associated with factors that are present during the periparturient period. At this time, we do TABLE Initial hematological data on 3 dogs with a severe nonregenerative anemia associated with myelofibrosis. not know the exact etiology of the myelofibrosis in the beagles, but the features of this disease process are reviewed to make people aware of this problem.
Hematology
The findings on 3 of the beagle dogs with spontaneous myelofibrosis will be discussed to illustrate some changes seen in these animals. These female dogs ranged in age from 3 to 5 yr. Initial presenting hematological data are listed in Table I . All of the dogs had a severe nonregenerative anemia. A similar moderate to severe nonregenerative anemia in dogs with myelofibrosis that was not associated with congenital hemolytic anemia has been previously described (9, 15, 16, 33, 35) . By evaluation of the erythrocyte indices, the anemia in the beagle dogs is characterized as macrocytic hypochromic. Although macrocytosis is often associated with a regenerative response, these animals had a nonregenerative anemia based on reticulocyte counts less than 60,000/wl. The exact mechanism for the macrocytosis is not clear. Other reports have not mentioned the presence of the macrocytosis as being a common feature of myelofibrosis (9, 16, 35) . It is thought that the hypochromasia [decrease in the mean cell hemoglobin concentration (MCHC)] is a false one.
A decrease in the MCHC may be seen in iron-deficient animals, but these beagle dogs were not irondeficient based on the presence of increased amounts of iron present in the Prussian blue-stained sections of bone marrow. Upon examination of the red blood cell histograms of these dogs, it was observed that due to the extremely low red blood cell counts, as well as the presence of large platelets in the blood, platelets were being falsely incorporated into the red blood cell count. This would lead to a falsely increased calculated packed cell volume (PCV). Since the MCHC is equal to the hemoglobin/PCV x 100, this then leads to a falsely decreased MCHC.
The hemopathology present in these dogs included anisocytosis and poikilocytosis. Although 1 dog had a rare dacrocyte seen upon scanning of the blood film, it was not a major finding in these beagles. Dacrocytosis has been documented in some dogs with myelofibrosis (35) but does not appear to be a common feature, as it was not mentioned in any of the 14 cases of myelofibrosis in dogs that were recently reviewed (16) . In contrast, dacrocytosis appears to be a common feature of primary myelofibrosis in people [reviewed by Hoffman and Silverstein (17)].
All 3 dogs had mild neutropenias and adequate to slightly increased numbers of platelets present. In other reports of myelofibrosis, changes in the leukon and thrombon are variable. The leukocyte and platelet counts were generally normal to slightly increased in most of the dogs in the review by Hoff et al (16) . In other cases, concurrent leukopenia and/ or thrombocytopenia have occurred (15, 16, 3 5) .
Histopathology
Even though hematologically the dogs looked very similar, they showed a wide spectrum of lesions in the antemortem bone marrow core biopsies examined. To determine whether or not myelofibrosis was present, sections of bone marrow were stained with hematoxylin and eosin, Mason's Trichrome, and Gomori silver stain and were evaluated similarly to other studies (4, 5, 34, 37) . In dog 10, approximately 50% of the marrow space was occupied by hematopoietic elements. Approximately 5-25% of the marrow space was fibrotic. Megakaryocytes, myeloid elements, and erythroid elements were all present in adequate numbers with an erythroid, pre-dominance. At necropsy, similar bone marrow changes were observed, and there was extramedullary hematopoiesis in the liver and spleen.
In dog 11, more than 75% of the marrow space was occupied by hematopoietic elements. There was no fibrosis documented. Megakaryocytes, myeloid elements, and erythroid elements were all present in adequate numbers with an erythroid predominance. Although this dog did not have myelofibrosis detected in the sections examined, this dog was included because of the similar changes that were present compared to the other dogs examined, including hematological abnormalities and erythroid hyperplasia. In addition, multifocal bone marrow necrosis and extramedullary hematopoiesis in the liver and spleen were found in this dog at necropsy. It may be that fibrosis would have been found in this dog if more sections of bone marrow were examined.
Also, due to the presence of the erythroid hyperplasia and bone marrow necrosis, the changes present in this dog may represent early stages of this disease process. Dog 12 had less than 25% of the marrow space occupied by hematopoietic elements (including megakaryocytes and myeloid and erythroid elements) and approximately 75% of the marrow space occupied by fibrosis. Multiple core biopsy specimens have had similar histopathological alterations.
At necropsy, similar bone marrow changes were observed, and there was extramedullary hematopoiesis in the liver and spleen.
ETIOLOGIES OF MYELOFIBROSIS IN DOGS
Naturally Occurring Myelofibrosis Naturally occurring secondary myelofibrosis has been documented in the dog in association with nonbone marrow origin malignancies (10, 35) , lymphoproliferative (35) and myeloproliferative disorders (33) , chronic hemolytic anemias (24, 25, 30) , and unidentified causes (15, 16, 33, 35) . Specifically, Weiss and Armstrong (35) documented a case of myelofibrosis in a dog with lymphosarcoma involving the bone marrow and a dog with metastatic adenocarcinoma without bone marrow involvement.
Both dogs had evidence of bone marrow necrosis. The dog with the metastatic adenocarcinoma had disseminated intravascular coagulation. This may have contributed to the bone marrow necrosis seen in this animal. A dog with Zollinger-Ellison syndrome associated with a pancreatic islet cell tumor that had concurrent myelofibrosis also has been documented (10) . Another case report of myelofibrosis was secondary to a myeloproliferative disorder classified as erythemic myelosis (33) . Myelofibrosis also has been seen during the chronic stages of hemolytic anemias in beagles with pyruvate kinase deficiency (24), Basenjis with pyruvate kinase deficiency (30) , and poodles with a congenital nonspherocytic hemolytic anemia (25) . In addition, in several cases the exact cause was undetermined (15, 16, 33, 35) .
Experimentally Induced Myelofibrosis
Experimentally, myelofibrosis has been induced by whole body gamma irradiation of dogs (31 ). During the clinical phase of the disease, these dogs had pancytopenia, with immature myeloid and erythroid elements in the circulation and extramedullary hematopoiesis in the spleen (31). Prolonged dietary exposure with 9°Sr in beagles produced a myeloproliferative disorder (granulocytic leukemia) in some dogs and myelofibrosis in others (8) . In addition, although not well documented in the literature, personal communications of this author with other clinical pathologists suggest that myelofibrosis has been seen in drug safety assessment studies.
PATHOGENESIS
The exact mechanisms responsible for the proliferation of the fibroblasts in both naturally and experimentally induced myelofibrosis in the dog is unknown, but several possible theories have been proposed. First, it is easiest to understand the occurrence of myelofibrosis after there is damage to the bone marrow. When there is bone marrow necrosis, there may be myelofibrosis (15, 36) . Potentially any agent that is directly toxic to the bone marrow hematopoietic elements or can damage the microvasculature of the bone marrow can lead to bone marrow necrosis. Bone marrow necrosis has occurred concurrently in dogs with Ehrlichiosis (36), estrogen toxicosis (15, 36) , and septicemia (36) . In addition, administration of drugs to dogs, including chromomycin (11) and cephalosporins (3) has been shown to cause bone marrow necrosis.
The necrosis may be subtle as well as patchy in distribution and a transient event so that it may not be recognized on a single section of bone marrow (15) . Therefore, if myelofibrosis is detected in a specimen, different sections of the specimen as well as samples from other sites of the bone marrow should be scrutinized for the presence of bone marrow necrosis. In dog 11 where bone marrow necrosis was seen, after resectioning of a block of affected bone marrow from this dog to obtain additional slides, the bone marrow necrosis could no longer be identified.
It is not clear whether the bone marrow necrosis that is associated with the different agents already listed is due to a direct effect on the bone marrow hematopoietic cells or due to an effect on the bone marrow microvasculature. If bone marrow necrosis and associated myelofibrosis are seen, one thing that may be done to investigate the pathogenesis is to determine whether or not disseminated intravascular coagulation is present. As mentioned previously, a dog with metastatic adenocarcinoma with myelonecrosis and myelofibrosis had disseminated intravascular coagulation (35) . Bone marrow necrosis has been documented in humans with disseminated intravascular coagulation (13, 27) . Some of the best experimental evidence that damage to the bone marrow microvasculature may be relevant to the pathogenesis of myelofibrosis comes from experimental studies in rabbits. Injection of saponin into rabbits causes myelofibrosis with the presence of nucleated red blood cells in the circulation and extramedullary hematopoiesis (1, 18) . Ultrastructural studies revealed that shortly after the injection of saponin into rabbits, there are changes to the vascular sinus of the bone marrow (1). This was further supported by Hoshi et al, who showed that 2 hr after saponin injection marked endothelial damage could be detected ultrastructurally (18) . At 4 hr postinjection, disruption of the bone marrow vascular sinus with hemorrhage in the hematopoietic space could be seen light microscopically (18) . As early as 1 wk postinjection, fibrosis could be seen.
The fibrosis became more pronounced at 2-4 wk postinjection (18) .
Association of hemosiderosis of the bone marrow
and secondary myelofibrosis has been documented (16, 25) . Hemosiderosis of the bone marrow is often pronounced in dogs with myelofibrosis of unknown etiology (16) and dogs with congenital hemolytic anemia with concurrent myelofibrosis (25) . But there does not appear to be a cause and effect relationship due to the presence of severe myelofibrosis in the presence of mild hemosiderosis (16) . The assessment of the amount of hemosiderin in the bone marrow of the dogs of this study leads to a similar conclusion.
Abnormalities in immunological tests documented in myelofibrosis in humans include the presence of antinuclear antibodies (26) , rheumatoid factor (26) , positive Coomb's test (26) , and deposition of immune complexes (6), but how relevant these changes may be to the disease process is not clear. Some of the beagle dogs with the severe nonregenerative anemia were Coomb's-positive; however, dogs 10-12 were all Coomb's-negative.
The role of growth factors in the proliferation of bone marrow fibroblasts has been investigated (7) . It may be that during injury to the bone marrow there are increased concentrations of growth factors present compared to the normal state and this leads to fibroblast proliferation. In support of this, Castro-Malaspina et al (7) showed that substances extracted from bone marrow megakaryocytes stimulated the proliferation of human bone marrow fibroblasts. Furthermore, there was a strong positive correlation between the number of megakaryocytes used to extract these growth factors and the amount of fibroblast proliferation (7) . In an attempt to further support this hypothesis, correlation between the number of megakaryocytes present in bone marrow sections and the degree of myelofibrosis has been investigated (4, 16) . Hoff et al (16) found that there was no correlation between the number of megakaryocytes in the bone marrow of dogs with myelofibrosis and the degree of the fibrosis, although others have suggested that it may not be dependent on the numbers of megakaryocytes present but just ineffective megakaryocytopoiesis with a release of growth factors (7) . Abnormalities in megakaryocytopoiesis have not been investigated in dogs with secondary myelofibrosis.
Specific types of growth factors that have been implicated in the stimulation of human bone marrow fibroblasts include platelet-derived growth factor, transforming growth factor ~i, and epidermal growth factor. All these growth factors can be found within platelets [2, 23, 28 ; reviewed by Ross et al (29) ]. Both platelet-derived growth factor (14, 21) and epidermal growth factor (21 ) stimulate the bone marrow fibroblast colony-forming cells. In addition, transforming growth factor ~3, platelet-derived growth factor, and epidermal growth factor stimulate the proliferation of bone marrow fibroblasts (21 ) . Recently, Katoh et al (20) measured the amount of platelet-derived growth factor activity in platelets from normal patients as well as those with myeloproliferative disorders. They found that platelet-derived growth factor activity per platelet was decreased in people with myeloproliferative disorders including primary myelofibrosis (20) . One possible explanation was that these factors may have been released from the platelets of these patients, which subsequently leads to the myelofibrosis (20) .
Another cell type that may play a role in the secretion of growth factors is the macrophage. In humans with idiopathic pulmonary fibrosis, alveolar macrophages have been shown to spontaneously release platelet-derived growth factor (22). In experimentally induced myelofibrosis in rabbits, macrophages are present in high numbers in the area of the fibrosis in the bone marrow sections (18) . Therefore, it seems reasonable that these cells may secrete growth factors into the area and subsequently lead to fibroblast proliferation. The exact role the bone marrow macrophage plays in the secretion of growth factors that stimulate fibroblast proliferation remains to be determined.
CONCLUSIONS
In summary, we have documented several cases of female beagles with secondary myelofibrosis of an unknown etiology. These dogs present with a severe nonregenerative anemia and often a mild neutropenia with varying degrees of myelofibrosis in the bone marrow. Some animals have had concurrent bone marrow necrosis. Many of the changes seen in these animals are similar to other reports of dogs with secondary myelofibrosis that have been documented in the literature. It is likely that the beagles with myelofibrosis had either direct damage to the hematopoietic elements or indirect damage to the hematopoietic elements due to changes in the microvasculature of the bone marrow. This then leads to fibroblast proliferation resulting in myelofibrosis. Further work is necessary to fully understand the pathogenesis of secondary myelofibrosis in these beagles and other dogs.
